Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...

Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...

Researchers have identified genetic variations in brain cells, particularly microglia and oligodendrocytes, that influence ...

The study reveals a potential link between concussions and the activation of dormant viruses, which may lead to ...

Individuals who suffer head trauma from sports, accidents, or other causes often go on to develop neurodegenerative diseases ...